|
| |
| Dr.
P. KALPANA MURTHY |
|
 |
.. |
Division of Parasitology
Central Drug Research Institute
Lucknow-226 001 |
| |
|
|
| |
| POST
DOCTORAL RESEARCH |
| |
Visiting Scientist CNRS-CSIR
bilateral Exchange programme, Pasteur, Institute, Paris, France,
1988
Senior Research Associate, Tulane Primate Research Centre, LA,
USA 1998 |
| |
| RESEARCH
EXPERIENCE |
| |
|
•
|
Chemotherapy
(30 yrs) |
|
•
|
Immunopathology
of filariasis (15 yrs) |
|
| |
| CURRENT
AREAS OF INTEREST |
| |
|
•
|
Drug Development,
Model Development and & Immunology of lymphatic Filariasis |
|
|
| SELECTED
PUBLICATIONS |
| |
|
•
|
Longitudinal
humoral immune responses of Indian leaf monkey (Presbytis
entellus) to Brugia malayi infection. P.K. Murthy,
K. Tyagi, R.P. Ghosh, P.S.R. Murthy, and R.K. Chatterjee.
Parasitology, 119: 53-60, 1999. |
|
•
|
Interleukin
10 modulates proinflammatory cytokines in the human monocytic
cell line THP-1 stimulated with Borrelia burgdorferi
lipoprotein. P.K. Murthy, V.A. Dennis, B.L. Lasater,
and T. Philipp. Mario. Infection and Immunity,
68: 6663-6669, 2000.
|
|
•
|
Preadult stage
of parasite is involved in the development of filarial
limb edema in Brugia malayi -infected Indian leaf
monkey (Presbytis entellus). P.K. Murthy,
M.A. Khan, H.B. Rajani, and V.M.L. Srivastava. Clin. Diag.
Lab. Immunol. 9:913-918, 2002. |
|
•
|
7-O-[4-methyl
piperazine-1- (2-acetyl0]-2H-1-benzopyran-2-one : A Novel
Antifilarial Lead Compound, R.P tripathi, V K Tiwari,
S Misra-Bhattacharya, K Tyagi, V M L Srivastava and
P K Murthy. Acta Tropica 87: 215-224, 2003 |
|
•
|
Response of
Brugia malayi- Indian Leaf Monkey (Presbytis entellus),
a non-human primate Model of Filariasis, to diethylcarbamazine,
ivermectin and CDRI Compond, 82-437. P K Murthy,
K Srivastava and P S R Murthy. Current Science
86: 432-39, (2004) |
| |
|
|
|
|
| |
|
| |
|